The Conversation
International · 2 hrs ago
✦ 78✓ Factual
Low-dose Zoladex won’t be available in Australia from November. What might that mean for you?
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 15/100
ObjectivePartisan
Low partisan intensity — consistent with factual reporting✓ Fair headline
AstraZeneca will discontinue low-dose Zoladex (goserelin) in Australia from November, affecting patients who use this hormone-suppressing medication for prostate cancer, endometriosis, and some breast cancers.
Low-dose Zoladex won’t be available in Australia from November. What might that mean for you?
Tom Werner/Getty
The drug goserelin – commonly known as Zoladex – has been a quietly crucial medicine in Australia for decades.
This prescription medicine is used to suppress sex hormones, and is a key medication for the treatment of prostate cancer, endometriosis and some breast cancers.
However, the international pharmaceutical company AstraZeneca has announced it will remove low-dose Zoladex from Australia’s Pharmaceutical Benefits Scheme (PBS) and pharmacy shelves from November. This has ma
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!